Channing Global Advisors LLC Has $205,000 Stake in CEMEX, S.A.B. de C.V. (NYSE:CX)

Channing Global Advisors LLC trimmed its holdings in shares of CEMEX, S.A.B. de C.V. (NYSE:CX) by 82.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,402 shares of the construction company’s stock after selling 120,530 shares during the period. Channing Global Advisors LLC’s holdings in CEMEX were worth $205,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Ballentine Partners LLC increased its holdings in CEMEX by 10.3% during the 4th quarter. Ballentine Partners LLC now owns 19,769 shares of the construction company’s stock valued at $153,000 after purchasing an additional 1,839 shares in the last quarter. Blue Trust Inc. boosted its position in CEMEX by 65.0% in the 4th quarter. Blue Trust Inc. now owns 5,232 shares of the construction company’s stock valued at $41,000 after buying an additional 2,062 shares during the last quarter. PNC Financial Services Group Inc. boosted its position in CEMEX by 40.6% in the 3rd quarter. PNC Financial Services Group Inc. now owns 8,501 shares of the construction company’s stock valued at $55,000 after buying an additional 2,454 shares during the last quarter. Creative Financial Designs Inc. ADV bought a new position in CEMEX in the 4th quarter valued at $26,000. Finally, Advisor Partners II LLC boosted its position in CEMEX by 10.1% in the 3rd quarter. Advisor Partners II LLC now owns 41,634 shares of the construction company’s stock valued at $271,000 after buying an additional 3,816 shares during the last quarter. 82.97% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have commented on the company. StockNews.com lowered CEMEX from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 9th. Bank of America lowered CEMEX from a “buy” rating to a “neutral” rating and set a $9.00 price objective on the stock. in a research report on Wednesday. Finally, Barclays lowered CEMEX from an “overweight” rating to an “equal weight” rating and set a $9.00 price target on the stock. in a research report on Friday, February 9th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $9.37.

CEMEX Stock Performance

CEMEX stock traded up $0.07 during midday trading on Friday, reaching $8.25. 1,456,041 shares of the company’s stock were exchanged, compared to its average volume of 6,655,595. CEMEX, S.A.B. de C.V. has a 52 week low of $5.67 and a 52 week high of $9.27. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.47 and a current ratio of 0.74. The firm has a market cap of $11.95 billion, a price-to-earnings ratio of 68.75, a P/E/G ratio of 0.16 and a beta of 1.47. The stock’s 50-day simple moving average is $8.31 and its 200 day simple moving average is $7.61.

CEMEX (NYSE:CX) last released its earnings results on Thursday, February 8th. The construction company reported ($0.30) earnings per share for the quarter. CEMEX had a return on equity of 1.50% and a net margin of 1.06%. The business had revenue of $4.24 billion for the quarter. On average, analysts expect that CEMEX, S.A.B. de C.V. will post 0.88 earnings per share for the current fiscal year.

CEMEX Profile

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products.